SEOUL,South Korea,Feb. 13,2025-- DAAN Biotherapeutics,a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies,has signed an exclusive licensing agreement w
FORNEBU,Norway,Feb. 13,2025-- Aker Horizons ASA (OSE:AKH),a developer of green energy and industry,today announced results for the fourth quarter 2024. Aker Horizons\' net capital employed stood at NO
SINGAPORE,Feb. 13,2025-- Cloud4C,a global leader in AI-driven cloud and cybersecurity services,has achieved two prestigious AI specializations on Microsoft Azure: \'AI Platform on Microsoft Azure\' an
This strategic partnership aims to transform professional advisory services by leveraging cutting-edge Generative AI to provide accurate,domain-specific insights
The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.
Overnight trading of all S&P 500®,Nasdaq-100® stocks and hundreds of ETFs is now available to all Schwab clients via the thinkorswim® platform suite